Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian Reich

Showing results (11-20 of 265) with videos related to

Pageof 27
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 21, 2013
Dear-Doctor-Letter Fumaderm® - What are the facts?Ulrich Mrowietz, Kristian Reich
Journal of the American Academy of Dermatology|November 26, 2008
Alefacept with methotrexate for treatment of psoriatic arthritis: open-label extension of a randomized, double-blind, placebo-controlled studyPhilip J Mease, Kristian Reich,
Archives of Dermatological Research|September 12, 2008
The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximabKristian Reich, Christopher E M Griffiths
Indian Journal of Dermatology, Venereology and Leprology|April 26, 2007
Use of fumaric acid esters in psoriasisAntonie Roll, Kristian Reich, Almut Boer
Nature Reviews. Drug Discovery|May 1, 2009
UstekinumabKristian Reich, Uma Yasothan, Peter Kirkpatrick
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 25, 2012
Methotrexate therapy in dermatologyKristian Reich, Silja Domm, Ulrich Mrowietz
The British Journal of Dermatology|April 20, 2022
Maintenance of response in moderate-to-severe psoriasis after withdrawal of the interleukin (IL)-17A and IL-17F nanobody sonelokimab: is there a role for IL-17F in disease reoccurrence?Kristian Reich, Eva Cullen, Mark Weinberg
Clinics in Dermatology|August 30, 2008
Tumor necrosis factor antagonists in the therapy of psoriasisRotraut Mössner, Michael P Schön, Kristian Reich
The New England Journal of Medicine|January 21, 2016
More on PML in Patients Treated with Dimethyl FumarateKristian Reich, Hans-Peter Hartung, Mark Lebwohl
Immunology|July 4, 2013
Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritisBruce W Kirkham, Arthur Kavanaugh, Kristian Reich
Pageof 27

Showing results (11-20 of 265) with videos related to

Sort By:
Pageof 27
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 21, 2013
Dear-Doctor-Letter Fumaderm® - What are the facts?Ulrich Mrowietz, Kristian Reich
Journal of the American Academy of Dermatology|November 26, 2008
Alefacept with methotrexate for treatment of psoriatic arthritis: open-label extension of a randomized, double-blind, placebo-controlled studyPhilip J Mease, Kristian Reich,
Archives of Dermatological Research|September 12, 2008
The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximabKristian Reich, Christopher E M Griffiths
Indian Journal of Dermatology, Venereology and Leprology|April 26, 2007
Use of fumaric acid esters in psoriasisAntonie Roll, Kristian Reich, Almut Boer
Nature Reviews. Drug Discovery|May 1, 2009
UstekinumabKristian Reich, Uma Yasothan, Peter Kirkpatrick
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 25, 2012
Methotrexate therapy in dermatologyKristian Reich, Silja Domm, Ulrich Mrowietz
The British Journal of Dermatology|April 20, 2022
Maintenance of response in moderate-to-severe psoriasis after withdrawal of the interleukin (IL)-17A and IL-17F nanobody sonelokimab: is there a role for IL-17F in disease reoccurrence?Kristian Reich, Eva Cullen, Mark Weinberg
Clinics in Dermatology|August 30, 2008
Tumor necrosis factor antagonists in the therapy of psoriasisRotraut Mössner, Michael P Schön, Kristian Reich
The New England Journal of Medicine|January 21, 2016
More on PML in Patients Treated with Dimethyl FumarateKristian Reich, Hans-Peter Hartung, Mark Lebwohl
Immunology|July 4, 2013
Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritisBruce W Kirkham, Arthur Kavanaugh, Kristian Reich
Pageof 27